Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

2010312 citationsJournal Articlehybrid Open Access

Authors

Combined BRAF/MEK inhibition may be one strategy to prevent the emergence of drug resistance in BRAF-V600E-mutated melanomas.

Good health and well-being

Published in: British Journal of Cancer

Volume 102, Issue 12, pp. 1724-1730

Field-Weighted Citation Impact: 14.60